Audited Unaudited
Financial Year Ended 31 December 2015 2016 2017 2018 2019
No. of Months 12 12 12 12 3
KEY FINANCIALS
STATEMENT OF COMPREHENSIVE INCOME
Revenue RM'000 29,720 47,123 55,917 70,090 12,482
Earnings Before Interest, Tax, Depreciation & Amortisation (EBITDA) RM'000 12,136 13,752 16,123 23,433 3,770
Profit Before Taxation (PBT) RM'000 7,303 7,737 9,375 14,693 1,266
Profit After Taxation (PAT) RM'000 6,458 7,924 7,477 11,603 944
 
RATIO ANALYSIS
PER SHARE DATA
Gross Earnings Per Share (Gross EPS) (1) sen 3.47 2.92 2.72 3.55 0.47
Net Earnings Per Share (Net EPS) (2) sen 1.47 1.27 0.97 1.35 0.10
Basic Earnings Per Share (Basic EPS) (3) sen 1.12 1.28 0.98 1.41 0.10
 
PROFITABILITY
PBT Margin % 24.57 16.24 16.77 20.96 10.14
PAT Margin % 21.73 16.82 13.37 16.55 7.56
 
WORKING CAPITAL RATIOS
Trade Receivables Turnover (4) days 197 187 198 186 266
Trade Payables Turnover (5) days 11 32 57 56 65
Inventory Turnover (6) days 168 103 103 95 135
 
Number of Shares in issue ('000) shares 463,413 666,666 809,249 860,209 860,209
Weighted Average Number of Ordinary Shares ('000) shares 604,599 663,601 803,637 819,485 860,209

Notes:-

(1) Calculated based on gross profit divided by the number of Shares in issue.
(2) Calculated based on net profit attributable to owners of the parent divided by the number of Shares in issue.
(3) Calculated based on net profit attributable to owners of the parent divided by the weighted average number of ordinary shares in issue.
(4) Calculated based on: Average trade receivables/Total revenue x 365 days for FYE 2012 to FYE 2015 and 274 days for FPE 30 September 2016
(5) Calculated based on: Average trade payables/Total cost of sales (excluded depreciation & amortisation) x 365 days for FYE 2012 to FYE 2015 and 274 days for FPE 30 September 2016
(6) Calculated based on: Average inventories/Total cost of sales (excluded depreciation & amortisation) x 365 days for FYE 2012 to FYE 2015 and 274 days for FPE 30 September 2016

* Please read this section in conjunction with Bioalpha Holdings Berhad's Prospectus dated 26 March 2015, Annual Reports and the latest Quarterly Report.